| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/28/2009 | US7524455 Methods for deposition of sensor regions onto optical storage media substrates and resulting devices |
| 04/28/2009 | US7524293 Method and apparatus for penetrating tissue |
| 04/28/2009 | US7523649 Method and apparatus for ultrasonic determination of hematocrit and hemoglobin concentrations |
| 04/28/2009 | US7523648 Apparatus and methods for solids deposition and analysis |
| 04/28/2009 | US7523647 Multiphase fluid characterization |
| 04/28/2009 | US7523646 Filtering and measuring apparatus for oils |
| 04/28/2009 | US7523638 Innovative gas monitoring with spacial and temporal analysis |
| 04/28/2009 | CA2591834C Determination of glycated hemoglobin by fluorescence quenching |
| 04/28/2009 | CA2591550C Monitoring hybridization during pcr |
| 04/28/2009 | CA2458066C System and method for evaluating pretest probabilities of life-threatening diseases |
| 04/28/2009 | CA2438986C Orientation device for a gas analyser |
| 04/28/2009 | CA2431399C Method for characterising a surface, and device therefor |
| 04/28/2009 | CA2418506C Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 04/28/2009 | CA2375453C Bidirectional lateral flow test strip and method |
| 04/28/2009 | CA2375450C Screening methods for altering circadian rhythm proteins |
| 04/28/2009 | CA2323584C Method and apparatus for testing surfaces |
| 04/28/2009 | CA2318984C Tumor tissue microarrays for rapid molecular profiling |
| 04/28/2009 | CA2299922C Method for determining the concentration of gas in a liquid |
| 04/28/2009 | CA2123227C Method and composition for preserving antigens and process for utilizing cytological material produced by same |
| 04/28/2009 | CA2107856C Detection of antibiotics |
| 04/28/2009 | CA1341595C Procedure for obtaining dna, rna, peptides, polypeptides, or proteins byrecombinant dna techniques |
| 04/23/2009 | WO2009052519A2 Co-polymer stabilizers for hydrofluoroalkane dispersions |
| 04/23/2009 | WO2009052504A1 Systems for and methods of detecting mastitis |
| 04/23/2009 | WO2009052501A2 Method and apparatus for identifying and tracking biological fluid |
| 04/23/2009 | WO2009052467A1 Methods of identifying pi-3-kinase inhibitor resistance |
| 04/23/2009 | WO2009052299A2 Visual glucose sensor and methods of use thereof |
| 04/23/2009 | WO2009052183A1 Composition and method for measuring thallium influx and efflux |
| 04/23/2009 | WO2009052179A2 Feline pancreatic lipase |
| 04/23/2009 | WO2009052129A1 Device for assessing oil vitality without requiring a clean oil sample |
| 04/23/2009 | WO2009051742A1 Estimating compositional information from limited analytical data |
| 04/23/2009 | WO2009051734A1 Microchip-based devices for capturing circulating tumor cells and methods of their use |
| 04/23/2009 | WO2009051703A1 Ion-selective sensors |
| 04/23/2009 | WO2009051662A2 Lunasin-induced regulation of disease-related gene expression |
| 04/23/2009 | WO2009051432A2 Lab-on-a-chip and method of driving the same |
| 04/23/2009 | WO2009051427A2 A kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a method for detecting herceptin-sensitive her2 overexpressed cell using the same |
| 04/23/2009 | WO2009051410A2 Method of screening for rage-amyloid-beta peptide interaction inhibiting materials |
| 04/23/2009 | WO2009051277A1 Method for prediction of postoperative prognosis, and diagnosis kit |
| 04/23/2009 | WO2009051259A1 Biomarker for diagnosis of liver disease |
| 04/23/2009 | WO2009051238A1 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof |
| 04/23/2009 | WO2009051222A1 Ultraviolet protection effect evaluation method, evaluation device, evaluation program, and recording medium where the program is recorded |
| 04/23/2009 | WO2009051220A1 Antibody capable of specifically binding to aβ oligomer, and use thereof |
| 04/23/2009 | WO2009051201A1 Anti-bst2 antibody |
| 04/23/2009 | WO2009051032A1 Method of stabilizing hem protein and storage solution therefor |
| 04/23/2009 | WO2009051016A1 Silicon quantum dots and biological labeling agent using the same |
| 04/23/2009 | WO2009050886A1 Program, computer, and culture state analysis method |
| 04/23/2009 | WO2009050711A2 A diagnostic device for identifying rupture of membrane during pregnancy |
| 04/23/2009 | WO2009050635A2 Interaction of probe molecules and cells as a diagnostic marker |
| 04/23/2009 | WO2009050634A1 Diagnosis of diseases by measuring cell mediated extracellular matrix degradation |
| 04/23/2009 | WO2009050630A1 A chemotaxis assay based on oscillating gradients of chemotactic agents |
| 04/23/2009 | WO2009050530A1 Method and device for measuring the amount of a gas in a sealed liquid container |
| 04/23/2009 | WO2009050509A2 Colorimetric sensing and/or detection of dna sequences using ruthenium or osmium bipyridine complexes |
| 04/23/2009 | WO2009050484A1 Knockout mice for a p450 gene cluster |
| 04/23/2009 | WO2009050461A1 Diagnostic, predictive and prognostic testing for cancer |
| 04/23/2009 | WO2009050458A1 Cancer biomarker and uses thereof |
| 04/23/2009 | WO2009050453A2 Breast cancer associated antigen |
| 04/23/2009 | WO2009050444A1 Diagnostic methods for hiv infection |
| 04/23/2009 | WO2009050436A1 Testing apparatus and method with one-way action |
| 04/23/2009 | WO2009050435A1 Testing apparatus and method with dosing mechanis |
| 04/23/2009 | WO2009050431A1 Method and system for measurement of electrical stability of fluids |
| 04/23/2009 | WO2009050401A2 Method for analysing a metal monolith of a catalyst |
| 04/23/2009 | WO2009050388A1 Antibody against anthrax toxins |
| 04/23/2009 | WO2009050303A1 Prognostic molecular markers for et-743 treatment |
| 04/23/2009 | WO2009050300A1 Method and marker for diagnosing diabetes mellitus |
| 04/23/2009 | WO2009050277A2 Edta resistant s100a12 complexes (erac) |
| 04/23/2009 | WO2009050275A1 A protease-sensitive site in apolipoprotein a1, therapeutic and diagnostic implications |
| 04/23/2009 | WO2009050261A1 Preparation of samples for proteome analysis |
| 04/23/2009 | WO2009050014A1 Methods for prediction of the therapeutic success of breast cancer therapy |
| 04/23/2009 | WO2009049913A1 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 04/23/2009 | WO2009049892A1 Polypeptides comprising an annexin core domain, compositions, methods and use thereof |
| 04/23/2009 | WO2009049884A1 Phenobarbital derivatives useful in immunoassay |
| 04/23/2009 | WO2009049756A1 Apparatus and method for investigating the wear resistance of a surface of a road surfacing sample |
| 04/23/2009 | WO2009049745A1 Mouthpiece for a measuring device |
| 04/23/2009 | WO2009049582A1 Test device for measuring and forecasting the grip of road surface layers and method |
| 04/23/2009 | WO2009049406A1 Use of ps20 /wfdc1 and interferons to diagnose, monitor and treat viral diseases |
| 04/23/2009 | WO2009049366A1 Water analysis |
| 04/23/2009 | WO2009032827A3 Electroporative flow cytometry |
| 04/23/2009 | WO2009032456A3 Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state |
| 04/23/2009 | WO2009031045A3 Anti-chikungunya monoclonal antibodies and uses thereof |
| 04/23/2009 | WO2009029733A3 Method of providing a pattern of biological-binding areas for biological testing |
| 04/23/2009 | WO2009027708A3 Pulsed electrochemical sensor |
| 04/23/2009 | WO2009027388A3 Imaging medium comprising hyperpolarised 13c-acetate and use thereof |
| 04/23/2009 | WO2009026375A3 Spermicidal and microbicidal compositions |
| 04/23/2009 | WO2009024620A3 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 04/23/2009 | WO2009020343A3 Diagnostic composition and kit for renal cell carcinoma |
| 04/23/2009 | WO2009019368A3 Method for the assay of liver fatty acid-binding protein, ace and ca19-9 for the in vitro diagnosis of colorectal cancer |
| 04/23/2009 | WO2009019367A3 Apolipoprotein ai assay method for the in vitro diagnosis of colorectal cancer |
| 04/23/2009 | WO2009019230A3 Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease |
| 04/23/2009 | WO2009014563A9 Continuous monitor for cyanide and cyanogen blood agent detection in water |
| 04/23/2009 | WO2009013350A3 Imaging medium comprising hyperpolarised 13 c-lactate and use thereof |
| 04/23/2009 | WO2009012343A3 Arrays, substrates, devices, methods and systems for detecting target molecules |
| 04/23/2009 | WO2009010678A9 Method of determining the fuel content in a combustion engine lubricating oil |
| 04/23/2009 | WO2009000098A3 Sequence based engineering and optimization of single chain antibodies |
| 04/23/2009 | WO2008156510A3 Method for functionalizing materials and devices comprising such materials |
| 04/23/2009 | WO2008156428A3 Novel peptides and protein and uses thereof |
| 04/23/2009 | WO2008154543A3 Methods for treating juvenile idiopathic arthritis |
| 04/23/2009 | WO2008140483A3 Methods and antibodies for detecting protective antigen |
| 04/23/2009 | WO2008121894A3 Endogenous expression of hla-g and/or hla-e by mesenchymal cells |
| 04/23/2009 | WO2008115710A3 Biomarkers for cancer |
| 04/23/2009 | WO2008109440A3 Predicting response to a her dimerisation inhibitor based on low her3 expression |
| 04/23/2009 | WO2008084331A3 Biomarkers for renal disorders |